Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018

  • Report
  • 159 Pages
From
Focal Segmental Glomerulosclerosis (FSGS) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Focal Segmental Glomerulosclerosis (FSGS) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 85 Pages
From
Ophthalmology Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Ophthalmology Drug Development Pipeline Review, 2016

  • Report
  • 633 Pages
From
Glomerulonephritis - Pipeline Review, H1 2018 - Product Thumbnail Image

Glomerulonephritis - Pipeline Review, H1 2018

  • Report
  • 201 Pages
From
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H1 2018 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H1 2018

  • Report
  • 512 Pages
From
Focal Segmental Glomerulosclerosis (FSGS) - Pipeline Review, H2 2016 - Product Thumbnail Image

Focal Segmental Glomerulosclerosis (FSGS) - Pipeline Review, H2 2016

  • Report
  • 58 Pages
From
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2017 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2017

  • Report
  • 446 Pages
From
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2017 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2017

  • Report
  • 202 Pages
From
Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2017 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2017

  • Report
  • 402 Pages
From
Diabetic Retinopathy - Pipeline Review, H1 2018 - Product Thumbnail Image

Diabetic Retinopathy - Pipeline Review, H1 2018

  • Report
  • 219 Pages
From
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 1178 Pages
From
Multiple Sclerosis - Pipeline Review, H1 2017 - Product Thumbnail Image

Multiple Sclerosis - Pipeline Review, H1 2017

  • Report
  • 812 Pages
From
CCR2 Inhibitor -Pipeline Insight, 2018 - Product Thumbnail Image

CCR2 Inhibitor -Pipeline Insight, 2018

  • Drug Pipelines
  • 90 Pages
From
Dimerix Ltd - Product Thumbnail Image

Dimerix Ltd

  • Company Profile
  • 67 Pages
Dimerix Bioscience Pty Ltd Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis - Product Thumbnail Image

Dimerix Bioscience Pty Ltd Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

  • Company Profile
  • 30 Pages
From
Dimerix Bioscience Pty., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report - Product Thumbnail Image

Dimerix Bioscience Pty., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • Mergers and Acquisitions Profiles
  • 34 Pages
From
  • 16 Results (Page 1 of 1)
Loading Indicator
adroll